The objective of the study is to investigate whether peri-operative symbiotic treatment could reduce the risk of postoperative infections in patients undergoing elective colorectal surgery. This study was also designed to assess the risk-adjusted incidence and predictors of surgical site infections.

Symbiotic is a combination of prebiotics and probiotics that is designed to have synergistic or additive effects benefiting the host

Biological: Symbiotic

Oral symbiotic every 8 h since 2 days before operation; Symbiotic resumes postoperatively on day +2 until day +4 for a total of 4 d of treatment (12 doses).

Eligibility

Ages Eligible for Study:

14 Years and older

Genders Eligible for Study:

Both

Accepts Healthy Volunteers:

No

Criteria

Inclusion Criteria:

Both genders

More than 14 years old

Candidate for elective colorectal surgery

Exclusion Criteria:

Denied written informed consent,

Severe neutropenia, and

Critically ill condition

Not meeting inclusion criteria

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.